Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality
Ina Nemet, Xinmin S. Li, Arash Haghikia, et al.
European Heart Journal (2023) Vol. 44, Iss. 32, pp. 3085-3096
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction
Yu-Chen Wang, Yen Chin Koay, Calvin Pan, et al.
Circulation Research (2024) Vol. 134, Iss. 4, pp. 371-389
Open Access | Times Cited: 46
Exposome in ischaemic heart disease: beyond traditional risk factors
Rocco A. Montone, Massimiliano Camilli, Camilla Calvieri, et al.
European Heart Journal (2024) Vol. 45, Iss. 6, pp. 419-438
Open Access | Times Cited: 34
The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation
Olga Golubnitschaja, Jiří Polívka, Pavel Potuznik, et al.
The EPMA Journal (2024) Vol. 15, Iss. 1, pp. 1-23
Open Access | Times Cited: 21
Advancing lifelong precision medicine for cardiovascular diseases through gut microbiota modulation
Bozhong Shi, Haoyu Li, Xiaomin He
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease
Violeta Raverdy, Federica Tavaglione, Estelle Chatelain, et al.
Nature Medicine (2024) Vol. 30, Iss. 12, pp. 3624-3633
Open Access | Times Cited: 9
High interindividual variability of indoxyl sulfate production identified by an oral tryptophan challenge test
Ting‐Yun Lin, Wei‐Kai Wu, Ting‐Yun Lin
npj Biofilms and Microbiomes (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Indole‐3‐Lactic Acid Inhibits Doxorubicin‐Induced Ferroptosis Through Activating Aryl Hydrocarbon Receptor/Nrf2 Signalling Pathway
Jiangfang Lian, Hangyuan Guo, Zuoquan Zhong, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access | Times Cited: 1
The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications—2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum
Mariana X. Byndloss, Suzanne Devkota, Frank A. Duca, et al.
Diabetes Care (2024)
Open Access | Times Cited: 6
Gut microbiota-dependent phenylacetylglutamine in cardiovascular disease: current knowledge and new insights
Yaonan Song, Haoran Wei, Zhitong Zhou, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 1, pp. 31-45
Open Access | Times Cited: 5
Microbiome metabolite quantification methods enabling insights into human health and disease
Jarrod Roach, Rohit Mital, Jacob J. Haffner, et al.
Methods (2024) Vol. 222, pp. 81-99
Open Access | Times Cited: 5
The gut microbiota and diabetes: research, translation, and clinical applications – 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum
Mariana X. Byndloss, Suzanne Devkota, Frank A. Duca, et al.
Diabetologia (2024) Vol. 67, Iss. 9, pp. 1760-1782
Open Access | Times Cited: 5
The gut microbiota in thrombosis
My Phung Khuu, Nadja Paeslack, Olga Dremova, et al.
Nature Reviews Cardiology (2024)
Closed Access | Times Cited: 5
Salvia miltiorrhiza stem-leaf of total phenolic acid conversion products alleviate myocardial ischemia by regulating metabolic profiles, intestinal microbiota and metabolites
Ke Cai, Wen Zhang, Shulan Su, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117055-117055
Open Access | Times Cited: 4
Flavan-3-ols and Vascular Health: Clinical Evidence and Mechanisms of Action
Justyna Godos, Giovanni Luca Romano, Samuele Laudani, et al.
Nutrients (2024) Vol. 16, Iss. 15, pp. 2471-2471
Open Access | Times Cited: 4
Gut Microbiota and Their Metabolites as Modulators of Vascular Complications in Diabetes
Meng Yun Duan, Jielu Wen, Anning Chen, et al.
(2025), pp. 2-2
Open Access
Changes in Phenylacetylglutamine Levels Provide Add-On Value in Risk Stratification of Hypertensive Patients: A Longitudinal Cohort Study
Xuan Xu, Lixin Jia, Bokang Qiao, et al.
Metabolites (2025) Vol. 15, Iss. 1, pp. 64-64
Open Access
Association of Circulating Phenylacetylglutamine With Multi‐Vessel Coronary Disease Severity and Outcomes in ST‐Segment–Elevation Myocardial Infarction
Peng Zhao, Nana Dong, Yan Wang, et al.
Journal of the American Heart Association (2025)
Open Access
Microbial metabolite 4-ethylphenylsulfate (4EPS) interacts with AT1R, reduces blood pressure and outcome of AngII-induced aortic aneurysm
Terri J. Harford, Khuraijam Dhanachandra Singh, Triveni R. Pardhi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Circulating branched-chain amino acids and the risk of major adverse cardiovascular events in the UK biobank
Wanwan Sun, Ruilang Lin, Yiming Li, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Hypoglycemic mechanism of foxtail millet prolamin hydrolysate in type 2 diabetic mice revealed by metabolomics and 16S rRNA sequencing
Yiqing Zhu, Tong Wu, Yongxia Fu, et al.
Food Bioscience (2025), pp. 106187-106187
Closed Access
Yeast mannans promote laxation and specifically modulate microbiota composition in older adults: An open-label pilot study.
Matías Bedmar Moreno, Pieter Van den Abbeele, Aurélien Baudot, et al.
Nutrition Research (2025)
Open Access
Getting to the Heart of the Matter: Exploring the Intersection of Cardiovascular Disease, Sex and Race and How Exercise, and Gut Microbiota Influence these Relationships
John J. Guers, Kevin S. Heffernan, Sara C. Campbell
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 2
Open Access
Indoleacetylglutamine Pathway Is a Potential Biomarker for Cardiovascular Diseases
Khaled Naja, Najeha Anwardeen, Mashael Al-Shafai, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 377-377
Open Access
Efficacy of novel activated bamboo charcoal in reducing uremic toxins and enhancing kidney function in chronic kidney disease patients: a pilot randomized controlled trial
Kuo-Chin Hung, Mei‐Yueh Lee, Shih‐Yuan Hung, et al.
PeerJ (2025) Vol. 13, pp. e19007-e19007
Open Access
The gut microbiota-inflammation-HFpEF axis: deciphering the role of gut microbiota dysregulation in the pathogenesis and management of HFpEF
Shenghua Zhou, Xuan Zhou, Panpan Zhang, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top